Guardian Pharmacy Services Cash Flow Statement (2023-2025) | GRDN

Cash Flow Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -7.00M14.56M7.09M15.85M-105.82M11.84M9.27M8.83M9.59M
Share-based Compensation -22.72M5.95M-0.27M122.36M3.46M3.97M4.45M4.36M
Gains from Investment Securities 0.80M1.10M1.08M1.12M1.17M1.13M1.14M1.12M
Asset Writedowns and Impairment 1.36M1.40M1.74M1.11M2.13M0.90M1.01M1.21M
Cash from Operations 14.55M8.65M29.13M-2.16M22.34M17.55M19.94M28.17M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 4.71M4.75M4.87M4.99M5.15M5.27M5.49M5.84M
Change in Working Capital
Change in Receivables 2.34M9.54M5.61M2.13M8.20M1.01M-2.59M13.18M
Change in Inventory -0.85M1.83M-0.92M5.32M-5.08M2.88M-0.41M3.19M
Change in Account Payables -3.92M7.19M4.15M2.82M-0.93M1.87M1.88M17.40M
Change in Accured Expenses 23.25M-7.31M11.59M-20.68M5.35M5.84M-9.94M2.04M
Other Working Capital Changes 2.52M2.21M-0.92M-2.06M2.75M1.59M2.15M-4.60M
Investing Activities
Capital Expenditures 2.22M2.25M4.00M
Sales of Property, Plant and Equipment 1.62M0.09M0.19M0.26M0.13M0.26M0.22M0.24M
Cash from Investing Activities -1.15M-3.60M-13.10M-7.08M-6.62M-5.54M-13.00M-8.97M
Financing Activities
Other financing activities 0.35M0.28M0.87M0.95M2.05M1.53M0.06M0.03M
Cash from Financing Activities -13.28M-5.63M-14.66M44.93M-48.27M-2.67M-2.11M-1.53M
Dividend Payments
Dividends Paid - Common 4.75M3.68M4.31M6.29M0.18M0.14M0.05M
Additional items
Change in Cash 0.13M-0.58M1.36M35.68M-32.56M9.34M4.82M17.67M
Free Cash Flow 14.55M8.65M29.13M-4.38M20.09M17.55M19.94M24.17M
Net Cash Flow 0.13M-0.58M1.36M35.68M-32.56M9.34M4.82M17.67M